CDXS.NASDAQCodexis, INC

SCHEDULE: Opaleye Management Boosts Codexis Stake to 9.95%

Sentiment:

Schedule 13G Amendment


Opaleye Management Inc., along with Opaleye, L.P. and James Silverman, reported an aggregate beneficial ownership of 9.95% of Codexis, Inc.'s common stock.

Better than expectedThe disclosure of a significant stake (9.95%) by an institutional investor group, Opaleye Management Inc., is generally viewed positively by the market as it suggests confidence in the company's value or future prospects.Institutional investment can increase liquidity and potentially stabilize the stock price.

Summary

  • Opaleye Management Inc., Opaleye, L.P., and James Silverman collectively reported beneficial ownership of 8,987,989 shares of Codexis, Inc. common stock.
  • This represents 9.95% of the outstanding common stock of Codexis, Inc.
  • The percentage is based on 90,324,383 common shares outstanding as of November 3, 2025, as reported by Codexis, Inc. in its 10Q statement on November 6, 2025.
  • Opaleye Management Inc. serves as the investment adviser to Opaleye, L.P., and James Silverman controls Opaleye Management Inc.
  • The reporting persons share voting and dispositive power over these shares.
  • The filing certifies that the securities were not acquired for the purpose of changing or influencing control of the issuer, except for activities related to a nomination under Rule 14a-11.

Sentiment

Score: 7

Explanation: The filing indicates a significant institutional investment, which is generally a positive signal for the company's stock, reflecting confidence from a sophisticated investor. However, it's purely an ownership disclosure and doesn't contain operational or financial performance updates.

Positives

  • A significant institutional investor, Opaleye Management Inc., has disclosed a substantial stake of 9.95% in Codexis, Inc., potentially signaling confidence in the company's future prospects.
  • The shared voting and dispositive power indicates a coordinated investment strategy by the reporting group.

Negatives

  • No explicit negative information regarding Codexis, Inc. is presented in this ownership disclosure.

Risks

  • This filing, being an ownership disclosure, does not explicitly detail company-specific operational or financial risks for Codexis, Inc.

Future Outlook

The filing does not provide forward-looking statements or guidance from Codexis, Inc. or the reporting persons regarding the issuer's future performance.

Industry Context

This filing indicates a significant institutional investment in Codexis, Inc., a company typically operating in the biotechnology or life sciences sector. Such substantial stakes by investment advisers like Opaleye Management can draw market attention and are often interpreted as a vote of confidence in the company's long-term strategy or valuation, potentially influencing other investors in the sector.

Stakeholder Impact

  • Shareholders: The disclosure of a significant institutional stake may instill greater confidence among existing shareholders and attract new investors, potentially leading to increased demand and a positive impact on share price.
  • Management: The presence of a large institutional investor could lead to increased scrutiny or engagement from the investor regarding corporate strategy and performance, especially given the certification about potential nominations under Rule 14a-11.

Key Dates

DateDescription
2025-11-03Date of common shares outstanding reported by Codexis, Inc.
2025-11-06Date Codexis, Inc. reported common shares outstanding in its 10Q Statement.
2025-12-03Date of event requiring the filing of this statement.
2025-12-05Date of joint filing agreement and signatures on the Schedule 13G.

Recommendation

hold

While a significant institutional stake by Opaleye Management is a positive signal, this filing is purely an ownership disclosure and does not provide new financial or operational data to warrant a 'buy' or 'sell' recommendation. It suggests a seasoned investor sees value, but without further fundamental analysis of Codexis, Inc.'s business, a 'hold' is appropriate for existing investors, and further due diligence for potential new investors.

Keywords

Codexis Inc., Opaleye Management, Institutional Ownership, Schedule 13G, Common Stock, Investment Adviser, Beneficial Ownership, Biotechnology, Life Sciences

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.